Soma Y, Tohyama S, Kubo A, Yamasaki T, Kabasawa N, Haga K
iScience. 2024; 27(11):111234.
PMID: 39569381
PMC: 11576393.
DOI: 10.1016/j.isci.2024.111234.
Czosseck A, Chen M, Hsu C, Shamrin G, Meeson A, Oldershaw R
Stem Cell Res Ther. 2024; 15(1):363.
PMID: 39396003
PMC: 11470622.
DOI: 10.1186/s13287-024-03983-y.
Correia C, Christoffersson J, Tejedor S, El-Haou S, Matadamas-Guzman M, Nair S
Cells. 2024; 13(16.
PMID: 39195229
PMC: 11352932.
DOI: 10.3390/cells13161339.
Bonavida V, Ghassemi K, Ung G, Inouye K, Thankam F, Agrawal D
Rev Cardiovasc Med. 2024; 23(12):392.
PMID: 39076655
PMC: 11270456.
DOI: 10.31083/j.rcm2312392.
Ronan G, Bahcecioglu G, Yang J, Zorlutuna P
Biomaterials. 2024; 311:122671.
PMID: 38941684
PMC: 11344275.
DOI: 10.1016/j.biomaterials.2024.122671.
The HH-GLI2-CKS1B network regulates the proliferation-to-maturation transition of cardiomyocytes.
Waldron C, Kelly L, Stan N, Kawakami Y, Abrahante J, Magli A
Stem Cells Transl Med. 2024; 13(7):678-692.
PMID: 38761090
PMC: 11227970.
DOI: 10.1093/stcltm/szae032.
The network of cardiac K2.1: its function, cellular regulation, electrical signaling, diseases and new drug avenues.
Li E, van der Heyden M
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6369-6389.
PMID: 38683369
PMC: 11422472.
DOI: 10.1007/s00210-024-03116-5.
Integrated small RNA, mRNA and protein omics reveal a miRNA network orchestrating metabolic maturation of the developing human heart.
Aharon-Yariv A, Wang Y, Ahmed A, Delgado-Olguin P
BMC Genomics. 2023; 24(1):709.
PMID: 37996818
PMC: 10668469.
DOI: 10.1186/s12864-023-09801-8.
How to fix a broken heart-designing biofunctional cues for effective, environmentally-friendly cardiac tissue engineering.
Benko A, Webster T
Front Chem. 2023; 11:1267018.
PMID: 37901157
PMC: 10602933.
DOI: 10.3389/fchem.2023.1267018.
Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
Cheng Y, Hsieh M, Lin C, Chang C, Huang C, Puntney R
Circulation. 2023; 148(18):1395-1409.
PMID: 37732466
PMC: 10683868.
DOI: 10.1161/CIRCULATIONAHA.122.061736.
MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in NSCLC using a co-culture model.
Romitan M, Zanoaga O, Budisan L, Jurj A, Raduly L, Pop L
Biomol Biomed. 2023; 24(1):125-137.
PMID: 37622179
PMC: 10787611.
DOI: 10.17305/bb.2023.9272.
Engineering the maturation of stem cell-derived cardiomyocytes.
Hong Y, Zhao Y, Li H, Yang Y, Chen M, Wang X
Front Bioeng Biotechnol. 2023; 11:1155052.
PMID: 37034258
PMC: 10073467.
DOI: 10.3389/fbioe.2023.1155052.
Epigenetic Modification Factors and microRNAs Network Associated with Differentiation of Embryonic Stem Cells and Induced Pluripotent Stem Cells toward Cardiomyocytes: A Review.
Zare A, Salehpour A, Khoradmehr A, Bakhshalizadeh S, Najafzadeh V, Almasi-Turk S
Life (Basel). 2023; 13(2).
PMID: 36836926
PMC: 9965891.
DOI: 10.3390/life13020569.
Harnessing conserved signaling and metabolic pathways to enhance the maturation of functional engineered tissues.
Callaghan N, Durland L, Ireland R, Santerre J, Simmons C, Davenport Huyer L
NPJ Regen Med. 2022; 7(1):44.
PMID: 36057642
PMC: 9440900.
DOI: 10.1038/s41536-022-00246-3.
A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming.
Lyra-Leite D, Gutierrez-Gutierrez O, Wang M, Zhou Y, Cyganek L, Burridge P
STAR Protoc. 2022; 3(3):101560.
PMID: 36035804
PMC: 9405110.
DOI: 10.1016/j.xpro.2022.101560.
Cmarr/miR-540-3p axis promotes cardiomyocyte maturation transition by orchestrating Dtna expression.
Wu Y, Guo X, Han T, Feng K, Zhang P, Xu Y
Mol Ther Nucleic Acids. 2022; 29:481-497.
PMID: 36035750
PMC: 9382425.
DOI: 10.1016/j.omtn.2022.07.022.
The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation.
Cianflone E, Scalise M, Marino F, Salerno L, Salerno N, Urbanek K
Clin Sci (Lond). 2022; 136(16):1179-1203.
PMID: 35979890
PMC: 9411751.
DOI: 10.1042/CS20220391.
Cardiomyocyte Maturation-the Road is not Obstructed.
Wang Y, Yu M, Hao K, Lei W, Tang M, Hu S
Stem Cell Rev Rep. 2022; 18(8):2966-2981.
PMID: 35788883
DOI: 10.1007/s12015-022-10407-y.
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy.
Nicholson M, Ting C, Chan D, Cheng Y, Lee Y, Hsu C
Cells. 2022; 11(11).
PMID: 35681550
PMC: 9180434.
DOI: 10.3390/cells11111853.
Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.
Li J, Feng X, Wei X
Stem Cell Res Ther. 2022; 13(1):232.
PMID: 35659761
PMC: 9166443.
DOI: 10.1186/s13287-022-02905-0.